Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
10/2011
10/05/2011EP2370581A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
10/05/2011EP2370580A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
10/05/2011EP2370082A1 Drug composition cytotoxic for pancreatic cancer cells
10/05/2011CN102206240A Process for the synthesis of azacitidine and decitabine
10/05/2011CN102206239A Preparation method of capecitabine
10/05/2011CN101061131B Gemcitabine derivatives nanoparticles
10/04/2011US8030471 Plasmodium malariae and Plasmodium ovale genes and uses thereof
10/04/2011US8030096 Water-soluble rhodamine dyes conjugates
09/2011
09/29/2011WO2011119969A1 Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
09/29/2011WO2011119919A1 Adenosine compounds and their use thereof
09/29/2011WO2011119674A1 Methods and compositions related to modified adenosines for controlling off-target effects in rna interference
09/29/2011WO2011002200A3 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
09/29/2011US20110237787 High throughput nucleic acid sequencing by expansion
09/29/2011US20110237531 Method for producing sophorose lipid
09/29/2011US20110237529 Adenosine Analogs and Their Use
09/29/2011US20110236463 Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use
09/29/2011CA2792266A1 Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
09/29/2011CA2792265A1 Adenosine compounds and their use thereof
09/28/2011EP2367837A2 1'-substituted ribose 5'-polyphosphate analogs and their use as modulators of p2y receptor activity
09/28/2011CN102203111A Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides
09/28/2011CN102199183A C-di-GMP, analogues thereof and preparation method thereof
09/28/2011CN102199182A One-step extraction method for disodium 5'-inosinate
09/28/2011CN102199181A Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
09/28/2011CN102199180A Preparation method of capectabine
09/27/2011US8026356 Process for the large scale production of Stavudine
09/27/2011US8026348 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
09/27/2011US8026057 Nucleic acid labeling compounds
09/27/2011CA2493815C Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
09/27/2011CA2425112C Massive parallel method for decoding dna and rna
09/22/2011WO2011115818A1 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
09/22/2011WO2011115817A1 Methods of preparing 2'-o-substituted purine nucleosides
09/22/2011WO2011115513A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
09/22/2011WO2011113175A1 Cytarabine prodrug derivatives and use for resisting cancer or tumor thereof
09/22/2011WO2011113174A1 Cytarabine derivatives and uses for anticancer and antitumor thereof
09/22/2011WO2011113173A1 Cytarabine prodrug derivatives and use for resisting cancer or tumor thereof
09/22/2011US20110230436 Uracyl Cyclopropyl Nucleotides
09/22/2011US20110230435 Methods and Compositions for Treating Obesity and Related Disorders
09/22/2011US20110229918 Method of Quantifying Transient Interactions Between Proteins
09/22/2011US20110226610 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules
09/21/2011EP2045258B1 3'-ethynylcytidine derivative
09/21/2011CN102190695A Preparation method for 5'-deoxy-2',3'-diacetyl-5-fluorocytidine
09/20/2011US8022194 2′-nitrobenzyl-modified ribonucleotides
09/20/2011US8022193 6-modified bicyclic nucleic acid analogs
09/20/2011US8021839 Quantitative analysis; optical properties; kits
09/20/2011CA2676115C Nucleotide with an alpha-phosphate mimetic
09/20/2011CA2506532C Anhydrous crystalline azido cytosine hemisulfate derivative
09/20/2011CA2468552C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
09/15/2011WO2011112947A1 Methods and compositions comprising nucleic acid polymerization enhancers
09/15/2011WO2011111501A1 Rna containing nucleoside compound, method for controlling amount of protein production from that rna and nucleoside compound
09/15/2011US20110224422 Preparation of capecitabine
09/15/2011US20110224421 Preparation of intermediates useful in the synthesis of 2'-cyano-2'-deoxy-n4-palmi-toyl-1-beta-d-arabinofuranosylcytosine
09/15/2011US20110224099 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
09/15/2011US20110223677 Carboxamide-substituted dyes for analytical applications
09/14/2011EP2364989A1 Stable NAD/NADH-derivatives
09/14/2011EP2364988A1 Stable NAD/NADH derivatives
09/14/2011CN102186872A Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent
09/14/2011CN102180944A Remodeling and glycoconjugation of peptides
09/14/2011CN102180926A Monomers of 3'thio-hypoxanthine deoxyribonucleoside phosphoramidite and application thereof
09/14/2011CN102180925A Method for treating emulsion layer in process for synthesizing 5-methyluridine
09/14/2011CN102180924A L-ribo-LNA analogues
09/14/2011CN102180923A Method for stereoselective preparation of derivatives of pyrane
09/14/2011CN101497640B Novel crystal form of clofarabine
09/13/2011CA2378187C Methods for treating therapy-resistant tumors
09/09/2011WO2011108682A1 Ribonucleoside phosphorothioate manufacturing method
09/08/2011US20110218114 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate
09/07/2011EP2362811A2 Apparatus and method using rotary flow distribution mechanisms
09/07/2011CN102177172A Compounds and pharmaceutical compositions for the treatment of viral infections
09/07/2011CN102174038A Anti-viral nucleoside for treating viral infections
09/06/2011US8013147 Heterocyclic compounds and their use in the detection of nucleic acids
09/01/2011WO2011104540A1 One step process for the preparation of capecitabine
09/01/2011WO2011051733A3 Derivatives of uridine phosphate and their uses in protein binding assays
09/01/2011US20110212437 Single molecule sequencing with two distinct chemistry steps
09/01/2011US20110212030 Nucleic Acid Ligand Complexes
08/2011
08/31/2011EP2361922A1 Intermediate to HCV-Nucleoside Inhibitors
08/31/2011EP2361921A2 Novel bicyclonucleoside and oligonnucleotide analogue
08/31/2011EP2361256A1 Cyclohexenyl nucleic acid analogs
08/31/2011CN102171233A Process for preparing azacytidine intermediate
08/31/2011CN102171195A Synthesis of decitabine
08/31/2011CN102168123A Novel method for preparing deoxyribonucleoside triphosphate (dNMP)
08/31/2011CN102167716A Synthesis method of clofarabine, midbody thereof and preparation method of midbody
08/31/2011CN101676295B Method for purifying and separating 2'-deoxidized-2',2'-difluoro nucleotide
08/31/2011CN101381387B Method for preparing 2'-deoxy-2',2'-difluoro-beta-cytidine hydrochlorate
08/30/2011US8008308 Phosphonate compounds
08/30/2011US8008274 P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis
08/30/2011US8008007 S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases
08/30/2011US8008005 Method for the synthesis of DNA sequences
08/30/2011CA2610283C Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
08/30/2011CA2460911C 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
08/25/2011WO2011103468A2 Phosphoramidites for synthetic rna in the reverse direction
08/25/2011CA2790483A1 Phosphoramidites for synthetic rna in the reverse direction
08/24/2011EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011CN201942628U 肌苷生产中过滤装置 Inosine production filtration device
08/24/2011CN102164939A Antiviral nucleoside compounds
08/24/2011CN102161686A Method for preparing doxifluridine
08/23/2011US8003353 cyanocobalamin at 0.5%, citric acid 0.12%, sodium citrate 0.32%, glycerin 2.23%, benzalkonium chloride 0.02% and 96.79% water; elevating the vitamin B12 levels in the cerebral spinal fluid; intranasally spray
08/23/2011US8003324 Modulation of sodium channels by nicotinamide adenine dinucleotide
08/18/2011WO2011099443A1 Β-dihydrofuran deriving compound, method for producing β-dihydrofuran deriving compound or β-tetrahydrofuran deriving compound, β-glycoside compound, method for producing β-glycoside compound, and method for producing 4'-ethynyl d4t and analogue compounds thereof
08/18/2011US20110201800 Azacitidine process and polymorphs
08/18/2011US20110201674 Saporin-L1 inhibitors and uses thereof
08/18/2011US20110200569 Increasing the shelf life of bakery and patisserie products by using the antifungal lactobacillus amylovorus dsm 19280
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 201